Trial intelligence / Profile preview

Therapeutic Hepatitis B Vaccine in Antiviral-treated Chronic HBV Carriers

KCT0001249Phase 2Completed

Sponsor
AriBio Lab
Start
Nov 2014
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of Hepatitis B vaccine in Chronic Hepatitis B (CHB), sponsored by AriBio Lab. Started Nov 2014; status: completed.

02

Drugs

Hepatitis B vaccine
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on KCT0001249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0001249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call